InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
50%
T+90 mean return
-3.0%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by ORiordan Anne, Directeur. Director active across 1 company, notably Jazz Pharmaceuticals plc. Cumulatively, 6 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €64k. Activity tracked since 29 July 2021. The latest transaction was filed on 2 August 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
3,731 shares0Ordinary SharesSEC:0001765581-24-000076:0
3,075 shares0Ordinary SharesSEC:0001765581-23-000098:0
2,561 shares0Ordinary SharesSEC:0001765581-22-000094:0
457 shares@ US$148.920.0004% mcap100.0% of flowOrdinary SharesSEC:0001765581-22-000051:0
2,246 shares0Ordinary SharesSEC:0001765581-21-000079
2,246 shares0Ordinary SharesSEC:0001765581-21-000079:0
6 of 6 declarations
About ORiordan Anne
ORiordan Anne is a Director at Jazz Pharmaceuticals plc. In this role, she contributes to the governance of the company and strategic decision-making. Her experience in the pharmaceutical sector allows her to provide valuable insights into industry challenges. Anne is dedicated to the company's mission of improving patients' lives through innovative therapeutic solutions.
